Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Streptococcus thermophilus Attenuates Inflammation in Septic Mice Mediated by Gut Microbiota

  • 2020-12-15
  • Frontiers in Microbiology 11
    • F. Han
    • Gaofeng Wu
    • Yijie Zhang
    • Haotian Zheng
    • Shichao Han
    • Xiao-qiang Li
    • W. Cai
    • Jiaqi Liu
    • Wanfu Zhang
    • Xiaowei Zhang
    • D. Hu


Sepsis is a life-threatening organ dysfunction condition caused by a dysregulated host response to infection and lack of effective treatment method. Supplementation of probiotics has emerged as a potential biotherapy for inflammatory diseases in recent years, but its role in protecting viscera against the damage caused by sepsis and the underlying mechanism is poorly understood. Streptococcus thermophilus 19 is one of the most well-studied probiotics, which is selected in this study among seven strains isolated from homemade yogurt due to its optimal ability of suppressing the inflammation response in vitro. It showed significant decrease in the expression of TNF-α, IL-1β, and IL-6 in the co-culture of S. thermophilus 19 and LPS-treated mouse macrophage. The effect of S. thermophilus 19 in mice and the response of mice gut microbiota were subsequently investigated. In LPS-induced septic mouse model, S. thermophilus 19 was highly resistant to LPS and exhibited significantly decreased expressions of inflammatory factors compared to LPS-treated mice. A MiSeq-based 16S rDNA sequence analysis revealed that the decrease of gut microbial diversity in mice intraperitoneally injected with 1 mg/ml LPS were mitigated by the administration of S. thermophilus 19. Fusobacterium significantly decreased during the development of sepsis and rose again after supplement strain 19, while Flavonifractor showed the opposite trend, which demonstrated these two genera were the key bacteria that may function in the mice gut microbiota for alleviation of LPS-induced inflammation reaction. To conclude, S. thermophilus 19 may be a potential candidate for novel biotherapeutic interventions against inflammation caused by sepsis.

Keywords: Microbiome; inflammation; probiotics; sepsis; streptococcus thermophilus.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Streptococcus thermophilus SEBioticImproved Gut Microbial DiversityBeneficial
Streptococcus thermophilus SEBioticInflammatory Disease ProtectionBeneficial
Streptococcus thermophilus SEBioticReduced Inflammation LevelsBeneficial
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.

Join Our Community

Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.